Skip to content

Phase 3 Bunionectomy Study

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07490496
Enrollment
112
Registered
2026-03-24
Start date
2026-07-01
Completion date
2026-11-28
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bunion, Postoperative Pain

Keywords

bunionectomy, bunion, osteotomy

Brief summary

Patients with a bunion will have that repaired and then pain and rescue medicine use will be evaluated.

Detailed description

After signing an informed consent and then appropriate screening and meeting the inclusion and exclusion criteria, patients will have their bunion repaired under regional anesthesia. They will then stay in the facility for 72 hours while pain, rescue medication, and other criteria are assessed. A follow-up visit will occur at 7 days and 30 days after.

Interventions

DRUGCPL-01

Administration by the Surgeon during the operation

DRUGsaline placebo

Administration by the Surgeon during the operation

Sponsors

Cali Pharmaceuticals LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Bunionectomy

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Bunion

Exclusion criteria

* Concomitant conditions

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain with activity24 hoursAUC NRS-A wWOCF (Area Under the Curve of the Numeric Rating Scale sore for pain with Activity where 0 is no pain and 10 is worst pain imaginable)

Secondary

MeasureTime frameDescription
Postoperative Pain with rest24 hours, 72 hoursAUC NRS-R wWOCF (Area Under the Curve of the Numeric Rating Scale sore for pain at Rest where 0 is no pain and 10 is worst pain imaginable)
Postoperative rescue medication use24 hours, 72 hoursOpioid and non-opioid pain control medicines needed

Countries

United States

Contacts

CONTACTErol Onel, MD
e.onel@calibiosciences.com203-837-6500
PRINCIPAL_INVESTIGATORTodd Bertoch, MD

CenExel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026